SCHEMBL6564065

SCHEMBL6564065

CCc1cc(C(O)(CC)CC)ccc1-c1csc(COc2ccc(CO)c(CO)c2)c1

nearest known ligand 0.56

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
VDR P11473 3/20 0.56
SRD5A2 P31213 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6566504 0.91 VDR (0.50) VDR
SCHEMBL6562954 0.83 VDR (0.57) VDRSRD5A2
SCHEMBL6564597 0.82 VDR (0.61) VDR
SCHEMBL6564789 0.82 VDR (0.56) VDR
SCHEMBL2854911 0.77 VDR (0.88) VDR
SCHEMBL6566427 0.76 VDR (0.51) VDR
SCHEMBL6566493 0.76 VDR (0.51) VDR
SCHEMBL6563004 0.76 VDR (0.51) VDR
SCHEMBL6564164 0.75 VDR (0.77) VDR
SCHEMBL6564145 0.75 VDR (0.55) VDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235777-B1 VITAMIN D ANALOGUES GALDERMA RES & DEV (FR) 2004-06-16 EP claimed
EP-1235777-B1 VITAMIN D ANALOGUES GALDERMA RES & DEV (FR) 2004-06-16 EP disclosed
EP-1235777-A2 VITAMIN D ANALOGUES Galderma Research & Development, S.N.C. (FR) 2002-09-04 EP disclosed
WO-2001038303-A2 VITAMIN D ANALOGUES GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2001-05-31 WO disclosed